Crossmark

Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma

Crossref DOI link: https://doi.org/10.1245/s10434-015-5063-5

Published Online: 2016-01-12

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Ann Y.

Agaram, Narasimhan P.

Qin, Li-Xuan

Kuk, Deborah

Curtin, Christina

Brennan, Murray F.

Singer, Samuel
Funding

Funding for this research was provided by:

MFH Research Fund

Siskind Family Sarcoma Fund

National Cancer Institute (Memorial Sloan Kettering Cancer Center Core Grant, SPORE in Soft Tissue Sarcoma P50 CA140146)
License Information

Text and Data Mining valid from 2016-01-12